论文部分内容阅读
目的：观察沐舒坦用于新生儿肺炎的临床疗效。方法选取2012年5月至2013年5月东莞市常平医院收治的新生肺炎患儿84例，随机均分为观察组与对照组。对照组予以常规治疗，观察组在对照组基础上加以沐舒坦静脉滴注治疗，比较分析两组患儿的临床疗效。结果观察组患儿的症状改善时间、肺啰音消失时间及住院时间明显少于对照组，差异有统计学意义（P<0.05）；观察组患儿治疗的总有效率为95.24%，明显高于对照组的69.05%，差异有统计学意义（P<0.05）。结论沐舒坦应用于新生肺炎患儿，能有效改善患儿的体征和症状，疗效显著，值得临床推广应用。“,”ObjectiveAnalysis of the clinical efficacy of treatment in neonatal pneumonia mucosolvan.MethodsData selected 84 patients with pneumonia May 2012 May 2013 newborns admitted to our hospital were randomly divided into two groups, each group 42 cases, patients were treated with routine treatment, research group on this basis to Mu comfortable for intravenous infusion therapy, a comparative analysis of the clinical efficacy of two groups of children.ResultsThe study group to improve the symptoms of children with time, pulmonary rales disappeared time and length of hospital stay was significantly less than the control group, the difference was statistically significant (P<0.05); study groups were treated total effective rate 95.24%, significantly higher than the control 69.05% group, the difference was statistically significant (P<0.05).ConclusionAmbroxol used in the clinical treatment of patients with pneumonia in newborns, children can effectively improve the signs and symptoms of a significant effect, worthy of clinical application.